Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 9
2004 7
2005 6
2006 9
2007 6
2008 6
2009 4
2010 6
2011 13
2012 7
2013 8
2014 10
2015 9
2016 12
2017 11
2018 20
2019 17
2020 23
2021 15
2022 18
2023 20
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

217 results

Results by year

Filters applied: . Clear all
Page 1
Assessing vitamin D as a biomarker in inflammatory bowel disease.
Yeaman F, Nguyen A, Abasszade J, Gupta S, Bell S, Moore G. Yeaman F, et al. Among authors: moore g. JGH Open. 2023 Nov 27;7(12):953-958. doi: 10.1002/jgh3.13010. eCollection 2023 Dec. JGH Open. 2023. PMID: 38162852 Free PMC article.
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial.
Danese S, Panaccione R, Feagan BG, Afzali A, Rubin DT, Sands BE, Reinisch W, Panés J, Sahoo A, Terry NA, Chan D, Han C, Frustaci ME, Yang Z, Sandborn WJ, Hisamatsu T, Andrews JM, D'Haens GR; GALAXI-1 Study Group. Danese S, et al. Lancet Gastroenterol Hepatol. 2024 Feb;9(2):133-146. doi: 10.1016/S2468-1253(23)00318-7. Epub 2023 Dec 14. Lancet Gastroenterol Hepatol. 2024. PMID: 38104569 Clinical Trial.
Local fistula injection of allogeneic human amnion epithelial cells is safe and well tolerated in patients with refractory complex perianal Crohn's disease: a phase I open label study with long-term follow up.
Keung C, Nguyen TC, Lim R, Gerstenmaier A, Sievert W, Moore GT. Keung C, et al. Among authors: moore gt. EBioMedicine. 2023 Dec;98:104879. doi: 10.1016/j.ebiom.2023.104879. Epub 2023 Dec 1. EBioMedicine. 2023. PMID: 38042747 Free PMC article. Clinical Trial.
Overnight staffing in Canadian neonatal and pediatric intensive care units.
Maratta C, Hutchison K, Nicoll J, Bagshaw SM, Granton J, Kirpalani H, Stelfox HT, Ferguson N, Cook D, Parshuram CS, Moore GP. Maratta C, et al. Among authors: moore gp. Front Pediatr. 2023 Nov 1;11:1271730. doi: 10.3389/fped.2023.1271730. eCollection 2023. Front Pediatr. 2023. PMID: 38027260 Free PMC article.
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer.
Nolan-Stevaux O, Li C, Liang L, Zhan J, Estrada J, Osgood T, Li F, Zhang H, Case R, Murawsky CM, Estes B, Moore GL, Bernett MJ, Muchhal U, Desjarlais JR, Staley BK, Stevens J, Cooke KS, Aeffner F, Thomas O, Stieglmaier J, Lee JL, Coxon A, Bailis JM. Nolan-Stevaux O, et al. Among authors: moore gl. Cancer Discov. 2024 Jan 12;14(1):90-103. doi: 10.1158/2159-8290.CD-23-0984. Cancer Discov. 2024. PMID: 37861452
217 results